EA201991451A1 - ORGANIC CARE COMPOSITION - Google Patents

ORGANIC CARE COMPOSITION

Info

Publication number
EA201991451A1
EA201991451A1 EA201991451A EA201991451A EA201991451A1 EA 201991451 A1 EA201991451 A1 EA 201991451A1 EA 201991451 A EA201991451 A EA 201991451A EA 201991451 A EA201991451 A EA 201991451A EA 201991451 A1 EA201991451 A1 EA 201991451A1
Authority
EA
Eurasian Patent Office
Prior art keywords
phase
care composition
composition
calcium
weight
Prior art date
Application number
EA201991451A
Other languages
Russian (ru)
Other versions
EA039652B1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/078555 external-priority patent/WO2018108389A1/en
Publication of EA201991451A1 publication Critical patent/EA201991451A1/en
Publication of EA039652B1 publication Critical patent/EA039652B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/0233—Distinct layers, e.g. core/shell sticks
    • A61K8/0237—Striped compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/882—Mixing prior to application

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

Раскрыта двухфазная композиция для ухода за полостью рта, содержащая первую фазу, содержащую нерастворимый и/или малорастворимый в воде источник кальция в количестве от 20 до 75% в расчете на массу первой фазы композиции, вторую фазу, содержащую фосфат калия в количестве от 30 до 75% в расчете на массу второй фазы композиции, при этом первая фаза, кроме того, содержит усилитель закупорки канальцев, выбранный из дигидрофосфата кальция, полугидрата сульфата кальция или их смесей.Disclosed is a two-phase oral care composition containing a first phase containing an insoluble and/or slightly water-soluble source of calcium in an amount of 20 to 75% based on the weight of the first phase of the composition, a second phase containing potassium phosphate in an amount of 30 to 75 % based on the weight of the second phase of the composition, while the first phase, in addition, contains a tubular occlusion enhancer selected from calcium dihydrogen phosphate, calcium sulfate hemihydrate, or mixtures thereof.

EA201991451A 2017-01-19 2017-11-08 Oral care composition EA039652B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17152173 2017-01-19
PCT/EP2017/078555 WO2018108389A1 (en) 2016-12-14 2017-11-08 Oral care composition

Publications (2)

Publication Number Publication Date
EA201991451A1 true EA201991451A1 (en) 2019-11-29
EA039652B1 EA039652B1 (en) 2022-02-22

Family

ID=57850982

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991451A EA039652B1 (en) 2017-01-19 2017-11-08 Oral care composition

Country Status (1)

Country Link
EA (1) EA039652B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015189041A1 (en) * 2014-06-09 2015-12-17 Unilever Plc Oral care compositions
CN107809997B (en) * 2015-07-03 2021-05-11 荷兰联合利华有限公司 Oral care compositions

Also Published As

Publication number Publication date
EA039652B1 (en) 2022-02-22

Similar Documents

Publication Publication Date Title
BR112018013860A2 (en) Magnesium Phosphate Bone Cement
PH12018501956A1 (en) 3-desoxy derivative and pharmaceutical compositions thereof
EA201890193A1 (en) COMPOSITION FOR CARE OF THE ORAL CAVITY
MX2023010248A (en) Stable ascorbic acid compositions and methods of using the same.
EA201992116A1 (en) PHARMACEUTICAL COMPOSITIONS OF FLOROGLUCINOL AND TRIMETHYLFLOROGLUCINOL
MX2020000577A (en) Powdered formulations of cromolyn sodium and ibuprofen.
CO2023008643A2 (en) Anti-hla-g antibodies and their use
PH12019501105A1 (en) Oral care composition
PH12019500115A1 (en) Oral care composition
EA201691792A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON VILDAGLIPTINA
EA201991451A1 (en) ORGANIC CARE COMPOSITION
PH12016502386A1 (en) Oral care compositions
PH12019502342A1 (en) Oral care composition based on zinc oxide and calcium dihydrogen phosphate
EA202191446A1 (en) COMPOSITIONS FOR IMPROVING SEXUAL FUNCTIONS
CY1107466T1 (en) SOLUBLE COMPOSITIONS OF FERTILIZERS CONTAINING CALCIUM AND / OR MAGNESIUM PHOSPHORATES
EA202090827A1 (en) Oral Compositions for the Treatment of Gastroesophageal Reflux
EA201892408A1 (en) DEODORIZING PRODUCTS
EA201792582A1 (en) COMPOSITION FOR ATTACHING HAIR FORM
CY1124325T1 (en) NEW METHOD FOR THE PREPARATION OF WATER-SOLVENT FORSCOLIN
PH12018502339B1 (en) Oral care composition
EA201990498A1 (en) ORGANIC CARE COMPOSITION
PL427801A1 (en) Pharmaceutical composition based on kynurenic acid for prevention or reduction of overweight or obesity, and use of kynurenic acid
TR201721036A2 (en) MODULATED EMISSION FORMULATIONS OF FLURBIPROPHEN
PL425789A1 (en) Prebiotic composition containing calcium butyrate and magnesium butyrate and its application
MA47198A (en) COMBINATION OF MCL-1 INHIBITOR AND TAXANE COMPOUND, ITS USES AND PHARMACEUTICAL COMPOSITIONS INCLUDING IT